menu
    • menu

    Company profile for Kalos Therapeutics

    NEW Drugs in Dev: 1
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Kalos is developing a groundbreaking approach to treating cancers and related co-morbidities. The Company’s revolutionary technology is based upon leveraging a natural, known mechanism in the body to regulate cell growth. This natural mechanism has been adapted by the Company’s researchers into a safe nontoxic therapeutic that has the potential to inhibit the growth of rapidly dividing human cancer cells and put them into ...
    Kalos is developing a groundbreaking approach to treating cancers and related co-morbidities. The Company’s revolutionary technology is based upon leveraging a natural, known mechanism in the body to regulate cell growth. This natural mechanism has been adapted by the Company’s researchers into a safe nontoxic therapeutic that has the potential to inhibit the growth of rapidly dividing human cancer cells and put them into a sustained non-dividing state. This first-in-class approach to treating cancer is believed to be safe when administered to patients based upon other peptides.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Kalos TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2550 W Union Hills Dr, Suite 350 Phoenix, AZ 85027
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.kalostherapeutics.com/index.html
    Linkedin
    Linkedin
    https://www.linkedin.com/company/kalos-therapeutics
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/kalosinfo?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Natural Product Expo West

    Natural Product Expo West

    Not Confirmed

    envelop Contact Supplier

    Natural Product Expo West

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Kalos Medical Receives Korean MFDS Innovative Medical Device Designation
    Kalos Medical Receives Korean MFDS Innovative Medical Device Designation

    27 Jun 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/06/28/2695850/0/en/Kalos-Medical-Receives-Korean-MFDS-Innovative-Medical-Device-Designation-for-DENEX-Hypertension-Treatment-System.html

    GLOBENEWSWIRE
    27 Jun 2023
    Share Share
    Oncology Pharma Licensor and Co-Development Partner, Kalos Therapeutics
    Oncology Pharma Licensor and Co-Development Partner, Kalos Therapeutics

    22 Apr 2020

    // APNEWS

    https://apnews.com/a2735828da75c828d479e4cf378819ce

    APNEWS
    22 Apr 2020
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search